Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Activin A activation Drives Renal Fibrosis through the STAT3 Signalling Pathway

View through CrossRef
Abstract Background: The present study investigated whether TGF-β1 promotes fibrotic changes in HK-2 cells through the Activin A and STAT3 signalling pathways in vitro. Methods: Bioinformatics analysis of microarray profiles (GSE20247 and GSE23338) and a protein-protein interaction (PPI) analysis were performed to select hub genes. For the in vitro study, HK-2 cells were exposed to TGF-β1. The expression of Activin A and STAT3 was assayed, and the effect of Activin A and STAT3 expression on fibrosis was assessed (Collagen I and Fibronectin). Results: The bioinformatics study revealed TGF-β1 and Activin A as hub genes. The in vitro study showed that Activin A expression was significantly increased after TGF-β1 incubation. Blocking Activin A by follistatin attenuated TGF-β1-induced fibrosis. In addition, Activin A blockade attenuated TGF-β1-induced STAT3 signalling pathway activation and related fibrosis. More importantly, STAT3 inhibition by S3I-201 alleviated TGF-β1-induced fibrosis.Conclusion: Activin A promoted cellular fibrotic changes through the STAT3 signalling pathway. Attenuating Activin A expression to mediate the STAT3 signalling pathway might be a strategy for potent renal fibrosis treatment.
Springer Science and Business Media LLC
Title: Activin A activation Drives Renal Fibrosis through the STAT3 Signalling Pathway
Description:
Abstract Background: The present study investigated whether TGF-β1 promotes fibrotic changes in HK-2 cells through the Activin A and STAT3 signalling pathways in vitro.
Methods: Bioinformatics analysis of microarray profiles (GSE20247 and GSE23338) and a protein-protein interaction (PPI) analysis were performed to select hub genes.
For the in vitro study, HK-2 cells were exposed to TGF-β1.
The expression of Activin A and STAT3 was assayed, and the effect of Activin A and STAT3 expression on fibrosis was assessed (Collagen I and Fibronectin).
Results: The bioinformatics study revealed TGF-β1 and Activin A as hub genes.
The in vitro study showed that Activin A expression was significantly increased after TGF-β1 incubation.
Blocking Activin A by follistatin attenuated TGF-β1-induced fibrosis.
In addition, Activin A blockade attenuated TGF-β1-induced STAT3 signalling pathway activation and related fibrosis.
More importantly, STAT3 inhibition by S3I-201 alleviated TGF-β1-induced fibrosis.
Conclusion: Activin A promoted cellular fibrotic changes through the STAT3 signalling pathway.
Attenuating Activin A expression to mediate the STAT3 signalling pathway might be a strategy for potent renal fibrosis treatment.

Related Results

Abstract 1404: Novel STAT3 inhibitors targeting the STAT3 dimerization
Abstract 1404: Novel STAT3 inhibitors targeting the STAT3 dimerization
Abstract Background The STAT3 pathway may drive prostate cancer (PCa) progression to metastatic castration-resistant prostate cancer (mCRPC). STAT3 may serve as a go...
Abstract 1705: 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
Abstract 1705: 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
Abstract Approximately 13% of women are diagnosed with invasive breast cancer. Signal Transducer and Activator of Transcription 3 (STAT3) is a transcription factor t...
Activin-A Impedes the Establishment of CD4+ T Cell Exhaustion and Enhances Anti-Tumor Immunity in the Lung
Activin-A Impedes the Establishment of CD4+ T Cell Exhaustion and Enhances Anti-Tumor Immunity in the Lung
Abstract Background: Although tumor-infiltrating T cells represent a favorable prognostic marker for cancer patients, the majority of these cells are rendered with an exhau...
Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.
Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.
Abstract Abstract 2849 Poster Board II-825 Histone deacetylase inhibitors (HDACi) are emerging as a potential therapy for Multiple Myel...
O18 Molecular crosstalk between PLCγ1 and STAT3 in cutaneous T-cell lymphoma
O18 Molecular crosstalk between PLCγ1 and STAT3 in cutaneous T-cell lymphoma
Abstract Cutaneous T-cell lymphoma (CTCL) is a non-Hodgkin lymphoma of skin-homing T lymphocytes that is difficult to diagnose and treat due to a high degree of clin...
Intervening in the S1PR1/STAT3 Signaling Pathway Attenuates Valvular Damage Due to Rheumatic Heart Disease
Intervening in the S1PR1/STAT3 Signaling Pathway Attenuates Valvular Damage Due to Rheumatic Heart Disease
Abstract Background: Rheumatic heart disease (RHD) affects many patients every year, but its pathogenesis is still unclear. Recent studies have found that the sphingosine 1...
Activin‐A: a novel critical regulator of allergic asthma
Activin‐A: a novel critical regulator of allergic asthma
SummaryActivin‐A is a pleiotropic cytokine that belongs to the TGF‐β superfamily and plays an important role in fundamental biological processes, such as development and tissue rep...
STAT3 Protein–Protein Interaction Analysis Finds P300 as a Regulator of STAT3 and Histone 3 Lysine 27 Acetylation in Pericytes
STAT3 Protein–Protein Interaction Analysis Finds P300 as a Regulator of STAT3 and Histone 3 Lysine 27 Acetylation in Pericytes
Background: Signal transducer and activator of transcription 3 (STAT3) is a member of the cytoplasmic inducible transcription factors and plays an important role in mediating signa...

Back to Top